10-QPeriod: Q3 FY2013

EIDP, Inc. Quarterly Report for Q3 Ended Sep 30, 2013

Filed October 22, 2013For Securities:CTA-PBCTA-PA

Summary

E. I. du Pont de Nemours and Company (DuPont) reported strong financial results for the nine months ended September 30, 2013, driven by significant gains from the sale of its Performance Coatings business and an overall increase in net sales. For the third quarter of 2013, net sales rose 5% to $7.7 billion, with improved volume across key segments like Agriculture, Performance Chemicals, and Performance Materials, despite lower local prices and currency impacts. The company's strategic focus on growth areas, particularly Agriculture, is evident in its double-digit sales increase and improved profitability for the segment year-to-date, benefiting from higher seed prices and volumes, as well as reduced Imprelis® herbicide claims. DuPont's financial position was bolstered by the February 2013 sale of its Performance Coatings business, which generated a pre-tax gain of $2.7 billion and provided proceeds for a $1 billion share buyback. This strategic divestiture, coupled with disciplined cost management and ongoing restructuring savings, contributed to a 9% increase in income from continuing operations after taxes year-to-date, reaching $2.7 billion. The company continues to manage its capital resources effectively, with significant cash reserves and access to credit facilities, while also returning value to shareholders through dividends and share repurchases.

Financial Statements
Beta
Revenue$7.74B
Cost of Revenue$5.17B
Gross Profit$2.57B
R&D Expenses$540.00M
SG&A Expenses$774.00M
Operating Expenses$7.58B
Operating Income$741.00M
Interest Expense$108.00M
Net Income$288.00M
EPS (Basic)$0.30
EPS (Diluted)$0.30
Shares Outstanding (Basic)925.64M
Shares Outstanding (Diluted)933.00M

Key Highlights

  • 1Net sales for the third quarter increased 5% to $7.7 billion, driven by a 9% rise in volume across key segments.
  • 2The sale of the Performance Coatings business in February 2013 generated a pre-tax gain of $2.7 billion and funded a $1 billion share buyback.
  • 3Income from continuing operations after taxes for the nine months ended September 30, 2013, increased by 9% to $2.7 billion.
  • 4The Agriculture segment saw a 12% increase in sales year-to-date, with improved PTOI driven by volume growth, higher pricing, and reduced Imprelis® herbicide claims.
  • 5Total segment PTOI for the nine months was $4.8 billion, a 2% decrease, primarily due to a $0.9 billion decline in Performance Chemicals PTOI, offset by improvements in other segments.
  • 6Cash used for operating activities for the nine months was $(2.3) billion, a significant increase from $(0.4) billion in the prior year, largely due to changes in working capital in the Agriculture segment and the absence of prior-year asset impairment charges.
  • 7The company repurchased $1 billion of its stock through an accelerated share repurchase program in the first quarter, utilizing proceeds from the Performance Coatings sale.

Frequently Asked Questions

The primary driver was the $2.7 billion pre-tax gain recognized from the sale of the Performance Coatings business in February 2013. This event significantly boosted net income and provided funds for share repurchases.

The Performance Chemicals segment experienced a substantial decline in PTOI, with a $0.9 billion decrease year-to-date, primarily due to significantly lower global titanium dioxide prices. This decline offset improvements in other operating segments.

The company believes its ability to generate cash from operations, along with access to capital markets, will be adequate to meet its anticipated cash requirements. It has substantial cash reserves, marketable securities, and unused credit lines totaling approximately $4.4 billion.

Yes, DuPont is involved in several significant legal matters. Key among these are the Imprelis® herbicide claims, for which charges of $930 million were recorded as of September 30, 2013, with an estimated total cost up to $1.2 billion. Additionally, there are ongoing PFOA-related matters, including personal injury claims, and a $72 million charge was recorded in the third quarter for a settlement related to the titanium dioxide antitrust litigation.